Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
Duoenda (mitoxantrone liposomal)
i
Other names:
PLM60, 2010L04017, HE071
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
News
Trials
Company:
CSPC Pharma
Drug class:
Topoisomerase II inhibitor, DNA intercalator
Related drugs:
‹
doxorubicin hydrochloride (87)
etoposide IV (53)
etoposide oral (33)
pegylated liposomal doxorubicin (31)
epirubicin (29)
daunorubicin (20)
cytarabine/daunorubicin liposomal formulation (19)
idarubicin hydrochloride (16)
mitoxantrone (16)
dactinomycin (8)
teniposide (5)
MM-302 (4)
pixantrone (4)
non-pegylated liposomal doxorubicin (3)
pegylated liposomal doxorubicin (1)
IT-141 (1)
SGN-15 (1)
VLS-211 (1)
zoptarelin doxorubicin (1)
RTA 744 (1)
AVA6000 (0)
amsacrine (0)
amrubicin (0)
H-ferritin–nanocaged doxorubicin (0)
HF158K1 (0)
MNPR-202 (0)
non-pegylated liposomal doxorubicin (0)
vosaroxin (0)
amonafide (0)
SQ3370 (0)
THE001 (0)
lyso-thermosensitive liposomal doxorubicin (0)
tirapazamine (0)
idronoxil (0)
INNO-206 (0)
MNPR-201 (0)
NSC311152 (0)
dexrazoxane (0)
SA033 (0)
doxorubicin liposomal (0)
2X-111 (0)
NP-ACT D (0)
valrubicin (0)
aclarubicin (1)
echinomycin (0)
doxorubicin hydrochloride (87)
etoposide IV (53)
etoposide oral (33)
pegylated liposomal doxorubicin (31)
epirubicin (29)
daunorubicin (20)
cytarabine/daunorubicin liposomal formulation (19)
idarubicin hydrochloride (16)
mitoxantrone (16)
dactinomycin (8)
teniposide (5)
MM-302 (4)
pixantrone (4)
non-pegylated liposomal doxorubicin (3)
pegylated liposomal doxorubicin (1)
IT-141 (1)
SGN-15 (1)
VLS-211 (1)
zoptarelin doxorubicin (1)
RTA 744 (1)
AVA6000 (0)
amsacrine (0)
amrubicin (0)
H-ferritin–nanocaged doxorubicin (0)
HF158K1 (0)
MNPR-202 (0)
non-pegylated liposomal doxorubicin (0)
vosaroxin (0)
amonafide (0)
SQ3370 (0)
THE001 (0)
lyso-thermosensitive liposomal doxorubicin (0)
tirapazamine (0)
idronoxil (0)
INNO-206 (0)
MNPR-201 (0)
NSC311152 (0)
dexrazoxane (0)
SA033 (0)
doxorubicin liposomal (0)
2X-111 (0)
NP-ACT D (0)
valrubicin (0)
aclarubicin (1)
echinomycin (0)
›
Associations
News
Trials
Phase
Status
Apply
Phase
Status
Apply
Chidamide in Combination With Azacitidine, Liposomal Mitoxantrone, and Prednisone (CAMP Regimen) for the Treatment of Previously Untreated Nodal TFH Cell Lymphoma (NCT05958719)
Phase 2
Institute of Hematology & Blood Diseases Hospital, China
Institute of Hematology & Blood Disease...
Recruiting
Phase 2
Institute of Hematology & Blood Diseases Hospit...
Recruiting
Last update posted :
12/30/2024
Initiation :
03/02/2023
Primary completion :
12/30/2026
Completion :
03/02/2027
IFNG • IL6 • TNFA • IL10 • IFNA1
|
azacitidine • prednisone • Epidaza (chidamide) • Duoenda (mitoxantrone liposomal)
Share
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login